// App-Quantinova.ai

2478 : Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras – Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®

Researchers

Presenter

  • Denis Choquette

Principal Investigators

  • Louis Bessette

  • Louis Coupal

  • Kirsten Garces

Medical Centers

  • Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, Quebec, Canada

  • Groupe de Recherche en Rhumatologie et Maladies Osseuses, Sainte-Foy, Quebec, Canada

  • Institut de Recherche en Rhumatologie de Montreal, Montreal, Canada

  • Amgen Canada, Inc., Mississauga, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • TNF Receptor Superfamily Member 1B

  • Interferon

Drug/Treatment

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved